SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

INDV

Indivior Pharmaceuticals, Inc.
NASDAQHealth Care

Latest close: 32.45 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 15, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Oct 6, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Sep 17, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record52130 flagged findings
Reported transactions (Form 4)51since Jan 26, 2026 · and 20 other holdings
Corporate events (8-K)22since Mar 4, 2025

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 521)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 15, 268-K ↗Current report · Shareholder vote results new
  • Oct 6, 26Form 425 ↗Merger, acquisition or tender offer
  • Oct 6, 268-K ↗Current report · Other events
  • Sep 30, 26SCHEDULE 13G ↗Passive stake · Millennium Management LLC · 5.4% · event on Sep 23, 26
  • Sep 17, 26Form 425 ↗Merger, acquisition or tender offer
  • Sep 17, 268-K ↗Current report · Communication to the market · Other events
  • Sep 15, 268-K ↗Current report · A material agreement was terminated
  • Sep 11, 26424B3 ↗Securities offering
  • Sep 9, 26S-4/A ↗Merger, acquisition or tender offer · amendment
  • Aug 28, 26S-4 ↗Merger, acquisition or tender offer
  • Aug 27, 26Form 4 ↗Insider transaction
  • Aug 13, 26SCHEDULE 13D/A ↗Stake with intent to influence · Oaktree Capital Holdings, LLC · 0.8% · event on Aug 11, 26 · amendment
  • Aug 5, 26Form 4 ↗Insider transaction
  • Aug 4, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 3, 2610-Q ↗Quarterly report
  • Aug 3, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 3, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 3, 268-K ↗Current report · Communication to the market
  • Aug 3, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 3, 268-K ↗Current report · Results · Communication to the market
  • Aug 3, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 3, 268-K ↗Current report · Entered a material agreement
  • Jul 13, 26Form 4 ↗Insider transaction
  • Jul 10, 26Form 144 ↗Notice of proposed sale
  • Jun 23, 26Form 4 ↗Insider transaction

521 filings on record, the oldest from Dec 7, 22.

Listing the 25 most recent filings of the 521 on record.

8-Ks, explained

Stress2Structure11Governance9
  • Sep 15, 26StructureA material agreement was terminated+1 more in the same filing8-K 1.02 ↗
  • Aug 3, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • May 15, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Mar 17, 26StructureSold unregistered shares+4 more in the same filing8-K 3.02 ↗
  • Jan 26, 26StructureEntered a material agreement+10 more in the same filing8-K 1.01 ↗
  • Dec 18, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Nov 20, 25StructureA material agreement was terminated+2 more in the same filing8-K 1.02 ↗
  • Oct 30, 25StressRestructuring plan with committed costs8-K/A 2.05 ↗
  • Aug 26, 25StressRestructuring plan with committed costs8-K 2.05 ↗
  • Governance4 senior executive changes2025show all 4hide
    • Aug 22, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Aug 4, 25GovernanceA senior executive left or was appointed8-K/A 5.02 ↗
    • Jun 24, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • May 8, 25GovernanceA senior executive left or was appointed+4 more in the same filing8-K 5.02 ↗
  • Mar 4, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Two Seas Capital LP5.0%Dec 23, 25SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 9 earlier filings
  • Oaktree Capital Holdings, LLC0.8%Aug 11, 26SCHEDULE 13D/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 4 earlier filings

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • BlackRock, Inc.14.3%Dec 31, 25SCHEDULE 13G/A ↗1 earlier filing
  • Vanguard Portfolio Management6.5%Mar 31, 26SCHEDULE 13G ↗
  • Millennium Management LLC5.4%Sep 23, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Vanguard Capital Management5.3%Mar 31, 26SCHEDULE 13G ↗
  • Fuller & Thaler Asset Management, Inc.3.7%Mar 31, 26SCHEDULE 13G/A ↗1 earlier filing
show 3 more holdershide
  • Deerfield Mgmt, L.P.3.7%Nov 10, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Madison Avenue International LP3.5%Mar 31, 26SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • THE GOLDMAN SACHS GROUP, INC.2.9%Dec 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Jul 10, Heidbreder Christian filed notice of intent to sell up to $765K. That is about 0.02% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $765K on Jul 10, per their Form 4. That is 100% of the shares announced.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 27, 26Buy$54KWoodrow D AndersonChief Accounting Officer↗
  • Aug 5, 26Buy$54KWoodrow D AndersonChief Accounting Officer↗
  • Jul 10, 26Sell$765KChristian HeidbrederChief Scientific Officer↗
  • Jun 11, 26Sell$707KChristian HeidbrederChief Scientific Officer↗
  • Jun 8, 26Sell$1.4MRyan PreblickChief Financial Officer↗
  • Mar 13, 26Buy$249Barbara Ryan↗
  • Mar 9, 26Buy$1KBarbara Ryan↗
  • Mar 6, 26Buy$30KStuart A Kingsley↗
Stock compensation, tax and giftsshow the 32 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jun 22, 26Compensationamount n/aJoseph CiaffoniChief Executive Officer↗
  • Jun 22, 26Tax$23.5MJoseph CiaffoniChief Executive Officer↗
  • May 13, 26Compensationamount n/aDANIEL A NINIVAGGI↗
  • May 13, 26Compensationamount n/aStuart A Kingsley↗
  • May 13, 26Compensationamount n/aMark Stejbach↗
  • May 13, 26Compensationamount n/aJuliet Thompson↗
  • May 13, 26Compensationamount n/aDavid E. Wheadon↗
  • May 13, 26Compensationamount n/aBarbara Ryan↗
  • May 13, 26Compensationamount n/aKeith Humphreys↗
  • May 12, 26Tax$43KJuliet Thompson↗
  • Mar 14, 26Compensationamount n/aRyan PreblickChief Financial Officer↗
  • Mar 14, 26Tax$88KRyan PreblickChief Financial Officer↗
  • Mar 3, 26Compensationamount n/aJeffrey W BurrisChief Legal Officer↗
  • Mar 3, 26Tax$1.2MJeffrey W BurrisChief Legal Officer↗
  • Mar 3, 26Compensationamount n/aWoodrow D AndersonChief Accounting Officer↗
  • Mar 3, 26Tax$265KWoodrow D AndersonChief Accounting Officer↗
  • Mar 3, 26Compensationamount n/aWoodrow D AndersonChief Accounting Officer↗
  • Mar 3, 26Tax$86KWoodrow D AndersonChief Accounting Officer↗
  • Mar 3, 26Compensationamount n/aChristian HeidbrederChief Scientific Officer↗
  • Mar 3, 26Tax$1.5MChristian HeidbrederChief Scientific Officer↗
  • Mar 3, 26Tax$2.8MRyan PreblickChief Financial Officer↗
  • Mar 3, 26Compensationamount n/aRyan PreblickChief Financial Officer↗
  • Feb 10, 26Compensationamount n/aJoseph CiaffoniChief Executive Officer↗
  • Feb 10, 26Compensationamount n/aJeffrey W BurrisChief Legal Officer↗
  • Feb 10, 26Compensationamount n/aPatrick A BarryChief Commercial Officer↗
  • Feb 10, 26Compensationamount n/aWoodrow D AndersonChief Accounting Officer↗
  • Feb 10, 26Compensationamount n/aChristian HeidbrederChief Scientific Officer↗
  • Feb 10, 26Compensationamount n/aRyan PreblickChief Financial Officer↗
  • Jan 26, 26Compensationamount n/aDANIEL A NINIVAGGI↗
  • Jan 26, 26Compensationamount n/aStuart A Kingsley↗
  • Jan 26, 26Compensationamount n/aMark Stejbach↗
  • Jan 26, 26Compensationamount n/aJuliet Thompson↗

The full record holds 48 transactions and goes back to Jan 1, 26.

Its sector and its market

Indivior Pharmaceuticals, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Indivior Pharmaceuticals, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Indivior Pharmaceuticals, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
521 documents on file, from Dec 7, 2022 to Oct 15, 2026.
Company description
No description available.
This page
Generated on Oct 18, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.